Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
01 Agosto 2024 - 5:05PM
Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company,
announced today that the company will release its second quarter
2024 financial results on Thursday, August 8, 2024, after U.S.
market close. The company will host a conference call and webcast
on Thursday, August 8, 2024, at 5:00 p.m. Eastern Time to discuss
its financial results and highlights.
Interested parties may access the live call via telephone by
dialing toll free 800-715-9871 for domestic callers. Once dialed
in, ask to be joined to the Oncocyte Corporation call.
The live webcast of the call may be accessed by visiting the
“Events & Presentations” section of the Company’s website
at https://investors.oncocyte.com. A replay of the webcast
will be available on the Company’s website shortly after the
conclusion of the call.
CONFERENCE CALL DETAILS
Participant Toll-Free
Dial-In Number: (800) 715-9871 Participant Toll Dial-In Number: +1
(646) 307-1963 Conference ID: 4153469
Webcast
https://events.q4inc.com/attendee/478523544
About OncocyteOncocyte is a diagnostics
technology company. The Company’s tests are designed to help
provide clarity and confidence to physicians and their patients.
VitaGraft™ is a clinical blood-based solid organ transplantation
monitoring test. GraftAssure™ is a research use only (RUO)
blood-based solid organ transplantation monitoring test. DetermaIO™
is a gene expression test that assesses the tumor microenvironment
to predict response to immunotherapies. DetermaCNI™ is a
blood-based monitoring tool for monitoring therapeutic efficacy in
cancer patients. For more information about Oncocyte, please
visit https://oncocyte.com/. For more information about our
products, please visit the following web pages:
VitaGraft Kidney™
- https://oncocyte.com/vitagraft-kidney/ VitaGraft Liver™
- https://oncocyte.com/vitagraft-liver/ GraftAssure™
- https://oncocyte.com/graftassure/ DetermaIO™
- https://oncocyte.com/determa-io/ DetermaCNI™
- https://oncocyte.com/determa-cni/
VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are
trademarks of Oncocyte Corporation.
Contact:Jeff Ramson
PCG Advisory
(646)
863-6893
jramson@pcgadvisory.com
Oncocyte (NASDAQ:OCX)
Gráfico Histórico do Ativo
De Jul 2024 até Ago 2024
Oncocyte (NASDAQ:OCX)
Gráfico Histórico do Ativo
De Ago 2023 até Ago 2024